The Female Reproductive Tract Microbiome—Implications for Gynecologic Cancers and Personalized Medicine

Epigenetic Regulation in Reproductive Medicine and Gynecologic Cancers

Copyright © 2010 Shi-Wen Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Recent progress in the field of epigenetics has provided a new study angle for our research efforts on reproductive medicine and gynecologic mal...

The importance of personalized medicine in urological cancers

Personalized medicine (PM) refers to a set of medical, diagnostic, and therapeutic activities and approaches based on the specific characteristics of each patient chr ('39')s genome. In fact, individual-centered medical approaches are based on personalization, meaning that each person chr ('39')s gene sequence and polymorphisms (SNPs) are different and explain the different courses of urologica...

Endocrine disruption of oestrogen action and female reproductive tract cancers.

Endocrine disrupting chemicals (EDC) are ubiquitous and persistent compounds that have the capacity to interfere with normal endocrine homoeostasis. The female reproductive tract is exquisitely sensitive to the action of sex steroids, and oestrogens play a key role in normal reproductive function. Malignancies of the female reproductive tract are the fourth most common cancer in women, with end...

Gynecologic and Reproductive Health for the Female Recruit

Leptotrichia amnionii and the Female Reproductive Tract

create a niche for M. tuberculosis (10). Our hypothesis could be refuted or corroborated in several ways, for example, by a case-control study of HIV-negative patients infected with tuberculosis. If this study refutes our hypothesis, the idea that sex hormones play a direct role in the immune response to M. tuberculosis would be supported. Such findings might also provide possibilities for drug...